中文名 | 莫能菌素 |
---|---|
英文名 | monensin A |
中文别名 | 莫能星钠 |
英文别名 |
1,6-Dioxaspiro[4.5]decane-7-butanoic acid, 2-[(2S,2'R,3'S,5R,5'R)-2-ethyloctahydro-3'-methyl-5'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl][2,2'-bifuran]-5-yl]-9- ;hydroxy-β-methoxy-α,γ,2,8-tetramethyl-, (αS,βR,γS,2S,5R,7S,8R,9S)-
monensicacid Monensin Elancoban Monelan Romensin MONENSIN SODIUM 1,6-dioxaspiro[4.5]decane-7-butanoic acid, 2-[(2S,2'R,3'S,5R,5'R)-2-ethyloctahydro-3'-methyl-5'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl][2,2'-bifuran]-5-yl]-9-hydroxy-b-methoxy-a,g,2,8-tetramethyl-, (aS,bR,gS,2S,5R,7S,8R,9S)- MONENSIN(PURE) MFCD00077826 EINECS 244-941-7 a3823a 1,6-dioxaspiro[4.5]decane-7-butanoic acid, 2-[(2S,2'R,3'S,5R,5'R)-2-ethyloctahydro-3'-methyl-5'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl][2,2'-bifuran]-5-yl]-9-hydroxy-β-methoxy-α,γ,2,8-tetramethyl-, (αS,βR,γS,2S,5R,7S,8R,9S)- (2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-{(2S,2'R,3'S,5R,5'R)-2-Ethyl-5'-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-3'-methyloctahydro-2,2'-bifuran-5-yl}-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]-3-methoxy-2-methylpentanoic acid MONENSIN NA |
描述 | Monensin 是由链霉菌属产生的脂溶性天然生物活性离子载体,它可以结合质子和一价阳离子。Monensin 在药物敏感和耐药菌株中均具有针对人类机会病原体的广谱活性。Monensin 能够诱导多种癌细胞系的凋亡。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 766.3±60.0 °C at 760 mmHg |
熔点 | 103-105°C |
分子式 | C36H61NaO11 |
分子量 | 670.871 |
闪点 | 229.2±26.4 °C |
精确质量 | 670.429199 |
PSA | 156.20000 |
LogP | 3.72 |
外观性状 | 白色或灰白色晶体 |
蒸汽压 | 0.0±5.9 mmHg at 25°C |
折射率 | 1.546 |
储存条件 | 2-8°C |
更多 | 1.性状:黄褐色或灰白色粉末 |
危害码 (欧洲) | T: Toxic; |
---|---|
风险声明 (欧洲) | R25 |
安全声明 (欧洲) | S36/37/39-S45 |
危险品运输编码 | UN 3462 6.1/PG 2 |
WGK德国 | 3 |
RTECS号 | JH2830000 |
包装等级 | II |
危险类别 | 6.1(a) |
上游产品 1 | |
---|---|
下游产品 2 | |